Cargando…
Next-generation sequencing corroborates a probable de novo GNPTG variation previously detected by Sanger sequencing
Autores principales: | Ludwig, Nataniel Floriano, Sperb-Ludwig, Fernanda, Velho, Renata Voltolini, Schwartz, Ida Vanessa D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470938/ https://www.ncbi.nlm.nih.gov/pubmed/28649512 http://dx.doi.org/10.1016/j.ymgmr.2017.02.002 |
Ejemplares similares
-
In vitro substrate reduction, chaperone and immunomodulation treatments reduce heparan sulfate in mucolipidosis III human fibroblasts
por: Sperb-Ludwig, Fernanda, et al.
Publicado: (2023) -
A de novo or germline mutation in a family with Mucolipidosis III gamma: Implications for molecular diagnosis and genetic counseling
por: Velho, Renata Voltolini, et al.
Publicado: (2014) -
Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma
por: Sperb-Ludwig, Fernanda, et al.
Publicado: (2019) -
Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III
por: Di Lorenzo, Giorgia, et al.
Publicado: (2021) -
Next Generation Sequencing identifies mutations in GNPTG gene as a cause of familial form of scleroderma-like disease
por: Zrhidri, Abdelali, et al.
Publicado: (2017)